184 related articles for article (PubMed ID: 9520171)
21. Oral Candida albicans isolates with reduced susceptibility to fluconazole in Swedish HIV-infected patients.
Chryssanthou E; Torssander J; Petrini B
Scand J Infect Dis; 1995; 27(4):391-5. PubMed ID: 8658076
[TBL] [Abstract][Full Text] [Related]
22. [Comparison of three antifungal susceptibility testing methods for the in vitro testing of Candida isolates from patients with HIV infection].
Ruhnke M; Schmidt-Westhausen A; Trautmann M
Mycoses; 1996; 39 Suppl 2():47-50. PubMed ID: 9198745
[TBL] [Abstract][Full Text] [Related]
23. Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis.
Martínez M; López-Ribot JL; Kirkpatrick WR; Bachmann SP; Perea S; Ruesga MT; Patterson TF
J Antimicrob Chemother; 2002 Mar; 49(3):515-24. PubMed ID: 11864952
[TBL] [Abstract][Full Text] [Related]
24. Itraconazole solution: summary of pharmacokinetic features and review of activity in the treatment of fluconazole-resistant oral candidosis in HIV-infected persons.
Koks CH; Meenhorst PL; Bult A; Beijnen JH
Pharmacol Res; 2002 Aug; 46(2):195-201. PubMed ID: 12220961
[TBL] [Abstract][Full Text] [Related]
25. Antifungal activity of a new triazole, D0870, compared with four other antifungal agents tested against clinical isolates of Candida and Torulopsis glabrata.
Pfaller MA; Bale MJ; Buschelman B; Rhomberg P
Diagn Microbiol Infect Dis; 1994 Jun; 19(2):75-80. PubMed ID: 7805359
[TBL] [Abstract][Full Text] [Related]
26. In vitro activity of rilopirox against fluconazole-susceptible and fluconazole-resistant Candida isolates from patients with HIV infection.
Nenoff P; Taneva E; Pfeil B; Oswald U; Haustein UF
Mycoses; 1999 Apr; 42(1-2):55-60. PubMed ID: 10394849
[TBL] [Abstract][Full Text] [Related]
27. In vitro activity of D0870 compared with those of other azoles against fluconazole-resistant Candida spp.
Wardle HM; Law D; Moore CB; Mason C; Denning DW
Antimicrob Agents Chemother; 1995 Apr; 39(4):868-71. PubMed ID: 7785986
[TBL] [Abstract][Full Text] [Related]
28. Fluconazole-resistant oral candidosis in a repeatedly treated female AIDS patient.
Thomas-Greber E; Korting HC; Bogner J; Goebel FD
Mycoses; 1994; 37(1-2):35-8. PubMed ID: 7935590
[TBL] [Abstract][Full Text] [Related]
29. Amphotericin B oral suspension for fluconazole-refractory oral candidiasis in persons with HIV infection. Adult AIDS Clinical Trials Group Study Team 295.
Fichtenbaum CJ; Zackin R; Rajicic N; Powderly WG; Wheat LJ; Zingman BS
AIDS; 2000 May; 14(7):845-52. PubMed ID: 10839593
[TBL] [Abstract][Full Text] [Related]
30. Oral Candida isolates among HIV-infected subjects in Nigeria.
Nweze EI; Ogbonnaya UL
J Microbiol Immunol Infect; 2011 Jun; 44(3):172-7. PubMed ID: 21524610
[TBL] [Abstract][Full Text] [Related]
31. ZD0870 treatment of murine candidiasis caused by fluconazole resistant isolates of Candida albicans.
Najvar LK; Correa A; James P; Luther MF; Graybill JR
J Antimicrob Chemother; 1996 Oct; 38(4):671-7. PubMed ID: 8937961
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of two multiple-dosing regimens of D0870 in human immunodeficiency virus-positive patients: a phase I study.
De Wit S; O'Doherty E; Edwards J; Yates R; Smith RP; Clumeck AN
Antimicrob Agents Chemother; 1998 Apr; 42(4):903-6. PubMed ID: 9559805
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of fluconazole and itraconazole in the treatment of oral candidiasis in HIV patients.
Menon T; Umamaheswari K; Kumarasamy N; Solomon S; Thyagarajan SP
Acta Trop; 2001 Oct; 80(2):151-4. PubMed ID: 11600094
[TBL] [Abstract][Full Text] [Related]
34. Variations in fluconazole susceptibility and DNA subtyping of multiple Candida albicans colonies from patients with AIDS and oral candidiasis suffering one or more episodes of infection.
Redding SW; Pfaller MA; Messer SA; Smith JA; Prows J; Bradley LL; Fothergill AW; Rinaldi MG
J Clin Microbiol; 1997 Jul; 35(7):1761-5. PubMed ID: 9196188
[TBL] [Abstract][Full Text] [Related]
35. Persistent oral candidosis by non-albicans Candida strains including Candida glabrata in a human immunodeficiency virus-infected patient observed over a period of 6 years.
Hoegl L; Thoma-Greber E; Röcken M; Korting HC
Mycoses; 1998; 41(7-8):335-8. PubMed ID: 9861840
[TBL] [Abstract][Full Text] [Related]
36. [Itraconazole suspension in the treatment of HIV-infected patients with fluconazole-resistant oropharyngeal candidiasis and esophagitis].
Eichel M; Just-Nübling G; Helm EB; Stille W
Mycoses; 1996; 39 Suppl 1():102-6. PubMed ID: 8767280
[TBL] [Abstract][Full Text] [Related]
37. Activity of fluconazole against Candida albicans isolates from HIV+ patients in a digestive candidosis turkey model.
Reynes J; Mallie M; Ravisse P; Bastide JM
J Med Vet Mycol; 1992; 30(5):363-7. PubMed ID: 1469537
[TBL] [Abstract][Full Text] [Related]
38. Fluconazole susceptibility of Candida isolates from oropharyngeal candidosis.
Dannaoui E; Lacoste V; Prat C; Piens MA
Mycoses; 1997 Nov; 40(7-8):279-82. PubMed ID: 9476510
[TBL] [Abstract][Full Text] [Related]
39. Fluconazole, D0870, and flucytosine treatment of disseminated Candida tropicalis infections in mice.
Graybill JR; Najvar LK; Holmberg JD; Luther MF
Antimicrob Agents Chemother; 1995 Apr; 39(4):924-9. PubMed ID: 7785997
[TBL] [Abstract][Full Text] [Related]
40. A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS.
Vazquez JA; Skiest DJ; Nieto L; Northland R; Sanne I; Gogate J; Greaves W; Isaacs R
Clin Infect Dis; 2006 Apr; 42(8):1179-86. PubMed ID: 16575739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]